The prognosis for a frontal lobe tumor depends on the specific tumor type, its diagnosed grade, and additional biological factors, according to the American Brain Tumor Association. Patients with frontal lobe tumors tend to have a more favorable prognosis than those with temporal or parietal tumors, states American Family Physician.
More than 120 different types of brain tumors are known as of 2015, as noted by the American Brain Tumor Association. The most aggressive forms of glioblastoma tumors result in a median patient survival time of 14.6 months and a two-year survival rate of 30 percent. Benign brain tumors are not cancerous, do not spread to other regions of the body, and are usually slow-growing with clearly defined borders, as described by WebMD. Due to these characteristics, many benign tumors can be surgically removed and do not recur, according to NHS Choices. Other tumor types usually have variable prognoses between these two examples.
Each case of a tumor is different. Emerging information as of 2015 regarding biological differences in tumors may offer insights about the outcomes among patients with brain tumors. The American Brain Tumor Association recommends that the prognosis for a specific tumor type be discussed with a physician.
